KOD
Price
$16.14
Change
+$0.38 (+2.41%)
Updated
Oct 2, 10:40 AM (EDT)
Capitalization
832.47M
41 days until earnings call
QLGN
Price
$6.01
Change
+$0.29 (+5.07%)
Updated
Oct 1 closing price
Capitalization
9.7M
Interact to see
Advertisement

KOD vs QLGN

Header iconKOD vs QLGN Comparison
Open Charts KOD vs QLGNBanner chart's image
Kodiak Sciences
Price$16.14
Change+$0.38 (+2.41%)
Volume$290
Capitalization832.47M
Qualigen Therapeutics
Price$6.01
Change+$0.29 (+5.07%)
Volume$586.72K
Capitalization9.7M
KOD vs QLGN Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. QLGN commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and QLGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (KOD: $15.76 vs. QLGN: $6.01)
Brand notoriety: KOD and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 81% vs. QLGN: 28%
Market capitalization -- KOD: $832.47M vs. QLGN: $9.7M
KOD [@Biotechnology] is valued at $832.47M. QLGN’s [@Biotechnology] market capitalization is $9.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.64B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 2 green FA rating(s).

  • KOD’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 2 green, 3 red.
According to our system of comparison, QLGN is a better buy in the long-term than KOD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while QLGN’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 4 bearish.
  • QLGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QLGN is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а +1.74% price change this week, while QLGN (@Biotechnology) price change was +45.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +12.74%, and the average quarterly price growth was +77.34%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($832M) has a higher market cap than QLGN($9.7M). KOD YTD gains are higher at: 58.392 vs. QLGN (42.755). QLGN has higher annual earnings (EBITDA): -6.28M vs. KOD (-170.11M). KOD has more cash in the bank: 104M vs. QLGN (332K). QLGN has less debt than KOD: QLGN (3.62M) vs KOD (65.2M). KOD (0) and QLGN (0) have equivalent revenues.
KODQLGNKOD / QLGN
Capitalization832M9.7M8,578%
EBITDA-170.11M-6.28M2,707%
Gain YTD58.39242.755137%
P/E RatioN/A0.95-
Revenue00-
Total Cash104M332K31,325%
Total Debt65.2M3.62M1,803%
FUNDAMENTALS RATINGS
KOD vs QLGN: Fundamental Ratings
KOD
QLGN
OUTLOOK RATING
1..100
2536
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3435
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (23) in the null industry is somewhat better than the same rating for KOD (61) in the Biotechnology industry. This means that QLGN’s stock grew somewhat faster than KOD’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as KOD (100) in the Biotechnology industry. This means that QLGN’s stock grew similarly to KOD’s over the last 12 months.

KOD's SMR Rating (99) in the Biotechnology industry is in the same range as QLGN (100) in the null industry. This means that KOD’s stock grew similarly to QLGN’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is in the same range as QLGN (35) in the null industry. This means that KOD’s stock grew similarly to QLGN’s over the last 12 months.

QLGN's P/E Growth Rating (1) in the null industry is significantly better than the same rating for KOD (100) in the Biotechnology industry. This means that QLGN’s stock grew significantly faster than KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODQLGN
RSI
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CABDX6.67N/A
N/A
AB Relative Value A
MUTHX26.86N/A
N/A
Franklin Mutual Shares Z
ALSAX10.97N/A
N/A
Alger Small Cap Growth A
PGSYX24.54N/A
N/A
Victory Pioneer Global Equity Y
AFGZX32.54N/A
N/A
Alger Global Equity Z

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with MBX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then MBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
+5.07%
MBX - QLGN
37%
Loosely correlated
+2.29%
NTLA - QLGN
34%
Loosely correlated
+8.63%
KOD - QLGN
33%
Poorly correlated
-3.73%
PHIO - QLGN
32%
Poorly correlated
-2.42%
ZLDAF - QLGN
29%
Poorly correlated
N/A
More